Results 51 to 60 of about 276 (89)

The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects. [PDF]

Neurotherapeutics
Toti A, Lucarini E, Ferrara V, Parisio C, Ciampi C, Gerace E, Micheli L, Margiotta F, Venturi D, Mello T, Lacal PM, Graziani G, Mannaioni G, Ghelardini C, Di Cesare Mannelli L.   +14 more
europepmc   +1 more source

Radiolabeled Vitamins and Nanosystems as Potential Agents in Oncology Theranostics: Developed Approaches and Future Perspectives. [PDF]

J Pers Med
Basirinia G, Comelli A, Alongi P, Ali M, Salvaggio G, Longo C, Di Raimondo D, Tuttolomondo A, Benfante V.   +8 more
europepmc   +1 more source

Possible role of hyperimmunoglobulin in reducing the risk of maternal-fetal transmission of cytomegalovirus in the valacyclovir era: a case series. [PDF]

Arch Gynecol Obstet
Barbiero A, Lilleri D, d'Angelo P, Zavaglio F, Tavanti M, Biagioni S, Ipponi A, Cecchi M, Borchi B, Trotta MS, Pasquini L, Bartoloni A, Zammarchi L.   +12 more
europepmc   +1 more source

Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. [PDF]

Cell Death Discov
Duranti C, Iorio J, Manganelli V, Bagni G, Colasurdo R, Lottini T, Martinelli M, Capitani C, Boso G, D'Alessandro FN, Sorice M, Becchetti A, Misasi R, Garofalo T, Arcangeli A.   +14 more
europepmc   +1 more source

Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD. [PDF]

Gut
Bamias G, Menghini P, Pizarro TT, Cominelli F.   +3 more
europepmc   +1 more source

Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patients. [PDF]

Sci Rep
Lisi S, Malerba F, Quaranta P, Florio R, Vitaloni O, Monaca E, Bruni Ercole B, Bitonti AR, Del Perugia O, Mignanelli M, Perrera P, Sabbatella R, Raimondi F, Piazza CR, Moles A, Alfano C, Pistello M, Cattaneo A.   +17 more
europepmc   +1 more source

Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment

, 2023
Focosi D, McConnell S, Sullivan DJ, Casadevall A.   +3 more
europepmc   +1 more source

Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients. [PDF]

Life (Basel)
Franchini M, Mengoli C, Casadevall A, Focosi D.   +3 more
europepmc   +1 more source

Network-based disease fingerprinting with neuroinflammation PET imaging. [PDF]

J Neuroinflammation
Barzon L, Maccioni L, Carranza Mellana M, Schubert JJ, Brusaferri L, Cousins O, Rosenzweig I, Mizuno Y, Marques TR, Harrison NA, Fryer T, Bullmore ET, Mondelli V, Pariante C, Sharp D, Scott G, Pereira JB, Howes O, Sossi V, Bodini B, Stankoff B, Loggia ML, Turkheimer FE, Veronese M.   +23 more
europepmc   +1 more source

Antineoplastic Activity of a Novel Trispecific Single-Chain Antibody Targeting the hERG1/β1 Integrin Complex and TRAIL Receptors. [PDF]

Mol Cancer Ther
Duranti C, Iorio J, Capitani C, Lottini T, Martinelli M, Roosz J, Anderle N, Maulana TI, Loskill PM, Colasurdo R, Sala C, Magni L, Arcangeli A.   +12 more
europepmc   +1 more source